Generic
- Empagliflozin
Description Empagliflozin, marketed as Empa 25, is a medication primarily used to improve glycemic control in adults with type 2 diabetes mellitus. It functions as an inhibitor of the sodium-glucose co-transporter-2 (SGLT2), facilitating increased excretion of glucose through urine, thereby lowering blood sugar levels.
Benefits
- Improves blood sugar control
- Reduces risk of cardiovascular death in patients with diabetes and established cardiovascular disease
- Aids in weight loss and blood pressure reduction
Ingredients
- Active Ingredient: Empagliflozin
- Inactive Ingredients: Vary by manufacturer
Uses and Doses
- To improve glycemic control in type 2 diabetes: Initially, 10 mg once daily, possibly increasing to 25 mg based on tolerance and need.
- To reduce cardiovascular risks: As per doctor's prescription.
Side Effects
- Urinary tract infections
- Genital fungal infections
- Increased urination
- Dehydration and hypotension
How to Use Take Empa 25 orally, once daily in the morning, with or without food. Swallow the tablet whole without crushing or chewing.
Pregnancy & Lactation
- Not recommended during the second and third trimesters of pregnancy.
- Not advisable for breastfeeding mothers due to the potential for serious adverse effects on the infant.
Precautions and Warnings
- Assess renal function before starting and monitor periodically.
- Not recommended for patients with severe renal impairment or on dialysis.
Safety Information
- Monitor for signs of dehydration and treat if necessary.
- Be aware of potential hypoglycemic events when used with insulin or insulin secretagogues.
Indications
- Type 2 diabetes mellitus
- Cardiovascular disease prevention in diabetic patients
Pharmacology Empagliflozin works by inhibiting SGLT2 in the kidneys, reducing glucose reabsorption and promoting its excretion in urine.
Therapeutic Class
- Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Storage Conditions
- Store at temperatures not exceeding 30°C.
- Keep out of reach of children.
FAQ
- Can Empa 25 be used for type 1 diabetes?
- No, it is contraindicated in type 1 diabetes.
- What should I do if I miss a dose?
- Take it as soon as you remember unless it's close to the time for your next dose. Do not double the dose.
- Can Empa 25 be taken with other diabetes medications?
- Yes, but monitoring for hypoglycemia is necessary.
Disclaimer This information is provided as a general reference and should not replace consultation with healthcare professionals.
Keyword: Mmpagliflozin, type 2 diabetes, SGLT2 inhibitor, blood sugar control, cardiovascular health, diabetes medication, weight loss, blood pressure, urinary tract infections, genital infections, dehydration, hypoglycemia, renal function, diabetes treatment, Empa 25.
Additional information
Weight | 0.1 kg |
---|---|
Dimensions | 2 × 4 × 1 in |
Class-Dosage | Tablet |
Size | 25mg |
Generics | Empagliflozin |
pharmaceuticals | Nipro JMI Pharma Ltd |
Reviews
There are no reviews yet.